secwatch / observer
8-K filed November 28, 2023, 6:59 PM ET ticker BGMS CIK 0001130166
regulatory confidence high sentiment negative materiality 0.65

Bio Green Med Solution, Inc. (BGMS): Nasdaq/NYSE listing notice — Cyclacel receives Nasdaq notice for late Q3 10-Q filing; 60 days to submit compliance plan

Bio Green Med Solution, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.93

Bio Green Med Solution, Inc. received a nasdaq noncompliance notice notice regarding late filing.

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
late filing
Exact text from the filing
November 21, 2023, Cyclacel Pharmaceuticals, Inc. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq’s continued listing standards because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Quarterly Report”). Under Nasdaq rules, the Company now has 60 calendar days (or until January 20, 2024) to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar da
View on SEC.gov

Browse all listing & compliance notices →

Bio Green Med Solution, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-121675
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.